ARX:ASX
Aroa Biosurgery Ltd
0,48Â AU$
arrow_downward
−1,02%(−0,0050) 1 p
20. nov, 16:10:08 GMT +11 · AUD
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse ARX põhistatistika genereerimine…
Ava
0,50Â AU$
Kõrge
0,50Â AU$
Madal
0,48Â AU$
Turu kapit.
167,76Â mln
Keskm. maht
259,42Â tuh
Maht
192,34Â tuh
Hinna ja tulu suhe
46,19
52 näd kõrgeim
0,78Â AU$
52 näd madalaim
0,46Â AU$
Aktsiatulu
0,01Â AU$
Käibivad aktsiad
345,90Â mln
Töötajate arv
261
Ava
0,50Â AU$
Kõrge
0,50Â AU$
Madal
0,48Â AU$
Turu kapit.
167,76Â mln
Keskm. maht
259,42Â tuh
Maht
192,34Â tuh
Hinna ja tulu suhe
46,19
52 näd kõrgeim
0,78Â AU$
52 näd madalaim
0,46Â AU$
Aktsiatulu
0,01Â AU$
Käibivad aktsiad
345,90Â mln
Töötajate arv
261
Uudised
Veebiallikatest ja uudistepartneritelt
AP News
·
16 tunni eest
S&P 500 sinks 3.7% and Nasdaq composite goes negative for the year as tech sell-off worsens
24/7 Wall St.
·
1 tunni eest
The Dow Jones Did Something It Hasn’t Done Since October 2008
Trefis
·
7 tunni eest
S&P 500 Movers | Winners: GPN, GIS, MKC | Losers: BE, NVDA, LITE
Profiil
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
Teave üksuse Aroa Biosurgery Ltd kohta